Home Cart Sign in  
Chemical Structure| 65-28-1 Chemical Structure| 65-28-1

Structure of 65-28-1

Chemical Structure| 65-28-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Phentolamine mesylate is a reversible and nonselective alpha-adrenergic receptor antagonist, used for the prevention or control of hypertensive episodes.

Synonyms: Phentolamine methanesulfonate; Phentolamine mesylate; Phentolamine (mesylate)

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Phentolamine methanesulfonate salt

CAS No. :65-28-1
Formula : C18H23N3O4S
M.W : 377.46
SMILES Code : CS(O)(=O)=O.CC1=CC=C(N(C2=CC(O)=CC=C2)CC3=NCCN3)C=C1
Synonyms :
Phentolamine methanesulfonate; Phentolamine mesylate; Phentolamine (mesylate)
MDL No. :MFCD00134201
InChI Key :OGIYDFVHFQEFKQ-UHFFFAOYSA-N
Pubchem ID :91430

Safety of Phentolamine methanesulfonate salt

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302+H312+H332-H315-H319-H335
Precautionary Statements:P261-P280-P301+P312+P330-P305+P351+P338

Related Pathways of Phentolamine methanesulfonate salt

GPCR

Isoform Comparison

Biological Activity

Target
  • α-adrenergic receptor

In Vitro:

Cell Line
Concentration Treated Time Description References
Rabbit aortic spiral strips 0.1 μM 2 hours To investigate the inhibitory effect of phentolamine on ergonovine-induced contractions in normal and atherosclerotic rabbit aortic spiral strips. Results showed that 0.1 μM phentolamine inhibited 1 μM ergonovine-induced contractions by 71% in normal arteries, while the same concentration of phentolamine only inhibited 54% in atherosclerotic arteries. PMC371712
Human periodontal ligament fibroblasts (HPDLFs) 25 μM 24 h or 48 h To investigate the effect of phentolamine on LPS-inhibited HPDLF proliferation, results showed that phentolamine significantly ameliorated LPS-inhibited cell proliferation. PMC4221694
Rabbit right atrium 0.1-10 μM 30 minutes Phentolamine inhibited the tachycardia induced by field stimulation in a concentration-dependent manner. This effect was prevented by benextramine treatment and antagonized 10-fold by yohimbine (1 μM) but not by prazosin (0.1 μM). PMC1986863
Mouse pancreatic β-cells 20-100 μM To study the inhibitory effects of phentolamine on ATP-sensitive K+ channels, results showed phentolamine significantly inhibited 86Rb efflux and ATP-sensitive K+ currents. PMC1917617
Mouse pancreatic β-cells 10 μM To investigate the inhibitory effect of Phentolamine on ATP-sensitive K+ channels and its impact on insulin release. Results showed that Phentolamine inhibited 86Rb efflux, indicating blockade of ATP-sensitive K+ channels, thereby increasing insulin release. PMC1907631
Guinea-pig detrusor smooth muscle cells 3 μM - 100 μM To investigate the effect of phentolamine on rhythmic contractions of detrusor muscle, results showed phentolamine induced concentration-dependent rhythmic contractions without affecting basal tone PMC1986976

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Rabbit Ganglion-blocked conscious or anaesthetized rabbits Intravenous injection 3-1000 μg/kg Single injection Phentolamine caused a dose-related rise in blood pressure in ganglion-blocked rabbits, which was antagonized by yohimbine (1 mg kg-1). In rabbits without ganglion blockade, phentolamine did not evoke a pressor response. PMC1986863
Mice Pancreatic β-cells Perifusion 20-100 μM To study the inhibitory effects of phentolamine on ATP-sensitive K+ channels, results showed phentolamine significantly inhibited 86Rb efflux and ATP-sensitive K+ currents. PMC1917617
Sprague-Dawley rats Hippocampal slices Perfusion 50 μM 30 minutes To study the long-term effects of NE and phentolamine on synaptic responses in the hippocampal dentate gyrus. Results showed that NE and phentolamine selectively potentiated responses to medial PP stimulation while depressing responses to lateral PP stimulation. PMC287356
Guinea-pig Detrusor smooth muscle strips Tissue bath 3 μM -100 μM Single administration To investigate the effect of phentolamine on rhythmic contractions of detrusor muscle, results showed phentolamine induced concentration-dependent rhythmic contractions without affecting basal tone PMC1986976
Rats Wistar WI/Ico, Wistar WAG/Rij, Fischer 344 Perfusion and superfusion 1μM 10 minutes To evaluate the efficiency of α2-adrenoceptor-mediated inhibition of noradrenaline release, results showed an increase in noradrenaline release in all ages and strains. PMC1510134

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03240822 Urologic Injuries ... More >> Genital Diseases, Male Amputation Less << Phase 1 Recruiting December 2025 United States, North Carolina ... More >> Wake Forest School of Medicine Recruiting Winston-Salem, North Carolina, United States, 27104 Contact: Mary-Clare Day, RN BSN    336-713-1343    Mday@wakehealth.edu Less <<
NCT01422616 Ischemic Stroke ... More >> High Blood Pressure Less << Phase 3 Recruiting February 2019 Australia, New South Wales ... More >> Royal Prince Alfred Hospital Recruiting Sydney, New South Wales, Australia, 2050 Contact: Craig S Anderson, MD    +61 2 933 4500    canderson@georgeinstitute.org.au Less <<
NCT00226096 CVA (Cerebrovascular Accident)... More >> Cerebral Hemorrhage Intracranial Hemorrhages Less << Not Applicable Completed - Australia, New South Wales ... More >> Concord Hospital Concord, New South Wales, Australia, 2138 Gosford Hospital Gosford, New South Wales, Australia, 2250 St George Hospital Kogarah, New South Wales, Australia, 2217 John Hunter Hospital Newcastle, New South Wales, Australia, 2310 St Vincent's Hospital Sydney, New South Wales, Australia, 2010 Royal Prince Alfred Hospital Sydney, New South Wales, Australia, 2050 Westmead Hospital Westmead, New South Wales, Australia, 2145 Australia, South Australia Royal Adelaide Hospital Adelaide, South Australia, Australia, 5000 Australia, Victoria Royal Melbourne Hospital Melbourne, Victoria, Australia, 3050 St Vincent's Hospital Melbourne, Victoria, Australia, 3065 Box Hill Hospital Melbourne, Victoria, Australia, 3128 Alfred Hospital Melbourne, Victoria, Australia, 3181 Austin Health Melbourne, Victoria, Australia Monash Medical Centre Melbourne, Victoria, Australia Australia, Western Australia Sir Charles Gairdner Hospital Perth, Western Australia, Australia, 6009 China Regional Coordinating Centre: Peking University First Hospital Beijing, China, 100034 Hospitals in China, c/o The George Institute China Beijing, China Regional Coordinating Centre: Centre for Epidemiological Studies and Clinical Trials, Ruijin Hospital, Shanghai Institute of Hypertension, Shanghai Second Medical University Shanghai, China, 200025 New Zealand North Shore Hospital Auckland, New Zealand Christchurch Hospital Christchurch, New Zealand Less <<
NCT01032694 - Terminated(This study was term... More >>inated January 11, 2011 due to low enrollment. This study is not being terminated because of safety or efficacy concerns.) Less << - -
NCT01032694 - Terminated(This study was term... More >>inated January 11, 2011 due to low enrollment. This study is not being terminated because of safety or efficacy concerns.) Less << - -
NCT03752957 - Not yet recruiting October 2019 -
NCT00577876 Prostate Cancer Not Applicable Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00104104 Multiple Myeloma Phase 4 Completed - -
NCT02966665 Chronic Obstructive Pulmonary ... More >>Disease Pulmonary Artery Hypertension Heart Failure Hypertension Less << Phase 1 Recruiting August 2020 United States, Utah ... More >> George E Wahlen VA Medical Center Recruiting Salt Lake City, Utah, United States, 84132 Contact: Russell Richardson, Ph.D.    801-582-1565    r.richardson@hsc.utah.edu    Contact: Ashley Nelson, MD    801-582-1565 ext 4127    ash.nelson@hsc.utah.edu Less <<
NCT00716079 Intracerebral Hemorrhage ... More >> Stroke Hypertension Less << Not Applicable Completed - -
NCT00104104 - Completed - -
NCT00080808 Prostate Cancer Phase 2 Completed - United States, Texas ... More >> M.D. Anderson Cancer Center at University of Texas Houston, Texas, United States, 77030-4009 Less <<
NCT00716079 - Completed - -
NCT00154167 Soft Tissue Anesthesia (Numbne... More >>ss) Less << Phase 2 Completed - United States, Washington ... More >> Northwest Kinetics Tacoma, Washington, United States, 98403 Less <<
NCT00132106 Heart Failure, Congestive Not Applicable Unknown - Netherlands ... More >> Radboud University Nijmegen Medical Centre Recruiting Nijmegen, Netherlands, 6500 HB Contact: Marc ER Gomes, MD    31-24-3614533/3616550    m.gomes@cardio.umcn.nl    Sub-Investigator: Marc ER Gomes, MD          Sub-Investigator: Alexandra H Mulder, MD          Sub-Investigator: Freek WA Verheugt, MD, PhD          Sub-Investigator: Paul Smits, MD, PhD          Principal Investigator: Cees J Tack, MD, PhD          Sub-Investigator: Louise Bellersen, MD Less <<
NCT02584686 Vasculogenic Erectile Dysfunct... More >>ion Less << Phase 1 Completed - Egypt ... More >> Cairo University Hospitals Cairo, Egypt, 11321 Less <<
NCT02584686 - Completed - -
NCT00309322 Anesthesia, Dental Phase 2 Completed - United States, Massachusetts ... More >> The Forsyth Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00309335 Anesthesia, Dental Phase 3 Completed - United States, Massachusetts ... More >> Tufts University School of Dental Medicine Boston, Massachusetts, United States, 02111 Less <<
NCT00309361 Anesthesia, Dental Phase 3 Completed - United States, Massachusetts ... More >> Tufts School of Dental Medicine Boston, Massachusetts, United States, 02111 Less <<
NCT03079921 Type1diabetes ... More >> Hypoglycemia Hypoglycemia Unawareness Less << Early Phase 1 Recruiting December 2020 United States, Pennsylvania ... More >> University of Pennsylvania - Institute for Diabetes, Obesity and Metabolism Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Eileen Markmann    215-350-0364    eileen.markmann@uphs.upenn.edu    Contact: Cornelia Dalton Bakes    2155274490 ext Dalton Bakes    cornelia.dalton-bakes@uphs.upenn.edu    Principal Investigator: Michael R Rickels, MD., MS Less <<
NCT03098680 Drug-Related Side Effects and ... More >>Adverse Reactions Cardiovascular System Disease Less << Phase 1 Recruiting February 29, 2020 United Kingdom ... More >> Addenbrooke's Hospital Recruiting Cambridge, Cambridgeshire, United Kingdom, CB2 0QQ Contact: Joseph Cheriyan, MBChB, MA, FRCP       jc403@medschl.cam.ac.uk Less <<
NCT03318094 Insulin Resistance ... More >> Healthy Obesity Less << Phase 1 Recruiting November 30, 2025 United States, Tennessee ... More >> Autonomic Dysfunction Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Misty D Hale, CCRP    615-343-8649    autonomics@vanderbilt.edu    Contact: Jorge E Celedonio    6153223304    autonomics@vanderbilt.edu Less <<
NCT03033537 - Completed - -
NCT02995291 Anesthesia, Local Phase 4 Recruiting February 2019 Canada, Nova Scotia ... More >> Dalhousie University Faculty of Dentistry Recruiting Halifax, Nova Scotia, Canada, B3H 4R2 Contact: Pierre-Luc Michaud, MSc    902-494-4264    PL.Michaud@Dal.ca    Principal Investigator: Pierre-Luc Michaud, MSc Less <<
NCT02861378 Soft Tissue Anaesthesia Not Applicable Completed - Canada, Nova Scotia ... More >> Dalhousie University Faculty of Dentistry Halifax, Nova Scotia, Canada, B3H 4R2 Less <<
NCT01703559 Night Vision Complaints Phase 2 Completed - United States, Arizona ... More >> Celerion Phoenix, Arizona, United States, 67230 Less <<
NCT01474382 Dental Anesthesia ... More >> Anesthesia, Local Anesthesia, Reversal Less << Phase 4 Completed - United States, California ... More >> University of California, San Francisco San Francisco, California, United States, 94143 United States, Indiana Indiana University School of Dentistry Indianapolis, Indiana, United States, 46202 United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Pennsylvania University of Pennsylvania School of Dental Philadelphia, Pennsylvania, United States, 19104-6030 University of Pittsburgh School of Dental Medicine Pittsburgh, Pennsylvania, United States, 15261 United States, Utah Jean Brown Research Salt Lake City, Utah, United States, 84124 United States, Washington Center for Pediatric Dentistry Seattle`, Washington, United States, 98115 Less <<
NCT03740386 Anesthesia, Local Not Applicable Completed - -

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.65mL

0.53mL

0.26mL

13.25mL

2.65mL

1.32mL

26.49mL

5.30mL

2.65mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
The prepared working fluid is recommended to be prepared now and used up as soon as possible in a short period of time. The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1

References

 

Historical Records

Categories